Fundz

Kodiak Sciences Inc. Completes $160 Million Public Offering

PUBLIC · KODDec 18, 2025

Amount Raised

$160 Million

Round Type

Post-IPO Equity

Palo AltoBiotechnologyEnergyOil And GasHealth CareTherapeuticsBiopharma

Investors

UBS Securities LLCEvercore Group L.L.C.Jefferies LLCJ.P. Morgan Securities LLC

Description

On December 16, 2025, Kodiak Sciences Inc entered into an underwriting agreement for a public offering of its common stock. The company will offer a total of 6,956,522 shares at a price of $23.00 per share. The underwriters include JP Morgan, Jefferies, Evercore, and UBS. An additional option for the underwriters allows for the purchase of up to 1,043,478 more shares.

Quick answer

Kodiak Sciences raised $160 Million in a Post-IPO Equity round, dated December 18, 2025. Investors: UBS Securities LLC, Evercore Group L.L.C., Jefferies LLC and J.P. Morgan Securities LLC. Kodiak Sciences is based in Palo Alto, California, United States.

How much did Kodiak Sciences raise?
Kodiak Sciences raised $160 Million in a Post-IPO Equity round on December 18, 2025.
Who invested in Kodiak Sciences?
UBS Securities LLC, Evercore Group L.L.C., Jefferies LLC and J.P. Morgan Securities LLC are named as investors in this round.
What does Kodiak Sciences do?
Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics.
Where is Kodiak Sciences based and how big is it?
Kodiak Sciences is based in Palo Alto, California, United States. Fundz records about 123 employees.
Who are the decision-makers at Kodiak Sciences?
Fundz holds 2 contacts at Kodiak Sciences, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Energy and Oil And Gas around the same time

Companies in the same sectors as Kodiak Sciences that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $3.5M on January 14, 2026.
  • Parabilis Medicines raised $305M (Series F) on January 8, 2026.
  • CASI Pharmaceuticals raised $5M on December 27, 2025.
  • Denali Therapeutics raised $200M (Post-IPO Equity) on December 10, 2025.
  • Citius Oncology raised $18M (Funding Round) on December 9, 2025.
  • BeyondSpring raised $2M (Funding Round) on November 21, 2025.

Who to call at Kodiak Sciences, and when

A new round usually means Kodiak Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kodiak Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kodiak Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kodiak Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kodiak Sciences

Location

Palo Alto, California, United States

About

Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC® Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies and has been at the core of Kodiak's discovery engine. We are developing a portfolio of three late-stage clinical programs. Tarcocimab and KSI-501 are being explored in two BLA-facing Phase 3 studies in the retinal vascular diseases. KSI-101 is a bispecific protein being explored in two Phase 3 studies in Macular Edema Secondary to Inflammation (MESI).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kodiak Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDolly C., Chief Scientific Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kodiak Sciences's next move

See what Strategic adds

Kodiak Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.